Reporter Aug 21 2015
Aug. 20, 2015—Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.
Aug. 20, 2015—Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC).
Aug. 20, 2015—Vanderbilt University School of Nursing (VUSN) is welcoming 427 new students pursuing Master of Science in Nursing, Doctor of Nursing Practice or Ph.D. degrees.
Aug. 20, 2015—The Vanderbilt Institute for Global Health (VIGH) has received two new grants from the Fogarty International Center of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Zambia, Mozambique and Brazil.
Aug. 20, 2015—Dawn Vanderhoef, Ph.D., DNP, has been named director of the Psychiatric Mental Health Nurse Practitioner Program at Vanderbilt University School of Nursing (VUSN).
Aug. 20, 2015—Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.